Despite solid IVD revenues, Surmodics (SRDX) reports a soft Q2 overall top line.
SurModics (SRDX) delivered earnings and revenue surprises of 31.25% and 6.99%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
EDEN PRAIRIE, Minn., April 27, 2022--Surmodics Reports Second Quarter Fiscal 2022 Results